Company news
Allergy Therapeutics Plc (LSE:AGY) news
Allergy Therapeutics Plc news releases on 6ix. Latest, Jul 6, 2015: Positive Dust Mite Study Results
Press releases — page 6
Positive Dust Mite Study Results
July 6, 2015
Company to Host Key Allergy Conference
July 2, 2015
Company to resume US clinical programme
June 25, 2015
Acquisition of Alerpharma S.A.
June 5, 2015
Result of General Meeting and Issue of Equity
March 30, 2015
Half Yearly Report
March 2, 2015
Change of Adviser
December 16, 2014
Appointment of a Non-Executive Director
November 18, 2014
Appointment of Head of Clinical Science
November 4, 2014
Amendment of 2012 Loan Note term
September 30, 2014
Exercise of Options
September 24, 2014
Shareholder update
September 4, 2014
Worthing Facility Licence Renewal
April 30, 2014
Extension of Convertible Loan Note
April 17, 2014
Health Canada approves submission of CTA
February 19, 2014
Results published in highly respected journal
January 27, 2014
Business and R&D Update
November 20, 2013
Notification under AIM Rule Schedule Two (g)
October 9, 2013
Notice of results and shareholder update
August 15, 2013
US patent granted
March 11, 2013
Update on Lincoln Medical Final
December 27, 2012
Annual Financial Report
October 16, 2012
FDA Clinical Hold Lifted
August 3, 2012
Voluntary recall of Anapen by Lincoln Medical
May 23, 2012
Board Appointment
May 2, 2012
Concert Party Shareholding
April 20, 2012
Result of Offer
April 18, 2012
Fundraising Announcement
March 30, 2012
Anapen? 500mcg epinephrine auto-injector
December 6, 2011
Regulatory update PEI FDA
November 28, 2011
AGM Statement
November 16, 2011
Provisional Grant of Options
September 29, 2011
Distribution Agreement
September 19, 2011
Allergy Therapeutics enters Latin America
August 23, 2011
Regulatory Update
June 8, 2011
FDA Update
April 26, 2011
Grass MATA MPL dossier submitted in Switzerland
April 7, 2011
Allergic rhinitis vaccination website launched
April 6, 2011
U.S. regulatory update
March 28, 2011
Ten further MAAs submitted in
December 1, 2010
Acquisition
July 1, 2010
Notification of Interim Resul
January 20, 2010
AGM Result
November 19, 2009
Annual General Meeting and No
November 16, 2009
Availability of Annual Report
October 19, 2009
Exercise of Warrants
September 25, 2009
Confirmation of Management Ch
September 1, 2009
European Patent Granted
July 23, 2009
Directors Holdings
July 10, 2009
Patent Granted in Japan
July 9, 2009